
GC69600
NX-2127
Also known as 3-[4-[1-[[(3S)-1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]pyrrolidin-3-yl]methyl]piperidin-4-yl]anilino]-5-piperidin-1-ylpyrazine-2-carboxamide
NX-2127 is an orally effective BTK inhibitor that can induce the degradation of mutated BTKC481S in cells· NX-2127 inhibits the proliferation of TMD8 cells with the BTKC481S mutation more effectively than Ibrutinib· NX-2127 catalyzes the degradation of Ikaros (IKZF1) and Aiolos (IKZF3), corresponding to concentrations of 25 nM and 54 nM, respectively· NX-2127 stimulates T cell activation and increases IL-2 production in primary human T cells
- CAS number
- 2416131-46-7
- Molecular weight
- 719.83
- Formula
- C39H45N9O5
- Solubility
- DMSO : 100 mg/mL (138·92 mM; Need ultrasonic)
- InChIKey
- XLWJWCMQMBVNSG-ACXKHFGCSA-N
- Catalogue number
- GC69600
- Brand
- GLPBIO
Computed properties PubChem CID 146559796 · XLogP 3.7 · TPSA 174 Ų · H-bond donors 3
- XLogP
- 3.7
- TPSA
- 174 Ų
- H-bond donors
- 3
- H-bond acceptors
- 11
- Rotatable bonds
- 9
- Heavy atoms
- 53
SMILES C1CCN(CC1)C2=CN=C(C(=N2)NC3=CC=C(C=C3)C4CCN(CC4)C[C@@H]5CCN(C5)C6=CC7=C(C=C6)C(=O)N(C7=O)C8CCC(=O)NC8=O)C(=O)N
Computed descriptors from PubChem (CID 146559796), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il